President Joe Biden and Vice President Kamala Harris announced a new Medicare initiative aimed at significantly reducing prescription drug prices for seniors by 2026, leveraging the 2022 Inflation Reduction Act that allows Medicare to negotiate drug prices. This initiative will lower the costs of ten widely-used medications by 38 to 79 percent, saving taxpayers $6 billion and Medicare enrollees $1.5 billion annually. The announcement, made in Maryland, marks a milestone in the Democrats' long-standing efforts to combat high drug prices and is seen as a significant victory against the pharmaceutical industry. The event also served as a platform for Biden to endorse Harris, the 2024 Democratic presidential nominee, highlighting her role in passing the legislation. However, concerns remain about potential impacts on pharmaceutical innovation and increased Medicare premiums. The savings and reduced prices are expected to alleviate financial burdens for millions of older Americans who rely on these medications for conditions such as diabetes and heart disease.